Cargando…
Development and external validation of prognostic nomograms for liver disease-free and overall survival in locally advanced rectal cancer with neoadjuvant therapy: a post cohort study based on the FOWARC trial
BACKGROUND: There is still a lack of nomograms that can accurately predict liver metastasis and poor prognosis after neoadjuvant therapy for locally advanced rectal cancer (LARC). Effective nomograms may help clinicians better identify LARC patients with potential high-risk risks, so as to carry out...
Autores principales: | Zhou, Jiaming, Li, Tuoyang, Xiao, Yuanlv, Lin, Jinxin, Chen, Xiaoqiong, Peng, Shaoyong, Huang, Mingzhe, Shi, Xuebin, Cai, Linbin, Huang, Pinzhu, Huang, Meijin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279784/ https://www.ncbi.nlm.nih.gov/pubmed/35845530 http://dx.doi.org/10.21037/atm-22-2790 |
Ejemplares similares
-
Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer
por: Zhuang, Zhuokai, et al.
Publicado: (2021) -
CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial
por: Hu, Huabin, et al.
Publicado: (2018) -
Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study
por: Zhang, Jianwei, et al.
Publicado: (2015) -
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation
por: Wu, Jingjing, et al.
Publicado: (2023) -
HBV Infection Status Indicates Different Risks of Synchronous and Metachronous Liver Metastasis in Colorectal Cancer: A Retrospective Study of 3132 Patients with a 5-Year Follow-Up
por: Zhou, Jiaming, et al.
Publicado: (2022)